Marek Murawski

ORCID: 0000-0001-9519-823X · 7 papers in corpus
review 2026
Journal of clinical medicine ·doi:10.3390/jcm15082891

Endometriosis and endometrial cancer are distinct gynecological conditions that share overlapping biological mechanisms with implications for clinical management. Endometriosis is a chronic, benign disorder characterized by the ectopic impl…

observational 2026
Journal of clinical medicine ·doi:10.3390/jcm15020787

Background/Objectives: This study explores the diagnostic and management pathways for dyspareunia in women seeking specialist care, focusing on gynecologists' feedback and women's perceptions of their experience. Methods: An online survey w…

case-report 2025
Journal of clinical medicine ·doi:10.3390/jcm15010190

Background and Clinical Significance: Herlyn-Werner-Wunderlich (HWW) syndrome, also known as OHVIRA syndrome (Obstructed HemiVagina and Ipsilateral Renal Anomaly), is a rare congenital anomaly of the female urogenital system characterized b…

review 2024
Cells ·doi:10.3390/cells13040345

Ovarian cancer is a leading cause of death among women with gynecological cancers, and is often diagnosed at advanced stages, leading to poor outcomes. This review explores genetic aspects of high-grade serous, endometrioid, and clear-cell …

observational 2016
Human cell ·doi:10.1007/s13577-015-0129-z

The aim of this study was to investigate the relationship between apoptotic markers present in human spermatozoa, namely phosphatidylserine translocation (PST) from the inner to the outer layer of the cytomembrane and the active form of cas…

lab-animal 2013
BioMed research international ·doi:10.1155/2013/849492

AIM: To assess the role of the Th1 and Th2 cellular response in the etiology of endometriosis observed in a rat model, with the use of the RESAN immunomodulator. MATERIALS AND METHODS: A comparative analysis of cytokines in blood serum typ…

lab-animal 2008
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2008.09.017

OBJECTIVE: The objective was to assess the effectiveness of the newly developed immunomodulator RESAN in the prophylaxis and treatment of endometriosis induced in rats. STUDY DESIGN: The study was performed on 58 Wistar rats. Twelve weeks …